AHA requests clarification of HRSA COVID-19 Uninsured Program
The AHA Saturday sent the Health Resources and Services Administration a letter requesting clarifications for several elements of the COVID-19 Uninsured Program.
Beginning May 6, 2020, providers may submit claims through the program for uninsured patients’ COVID-19 testing and treatment. The AHA urged HRSA to clarify coding guidance to ensure consistency with International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) guidelines, as well as reimbursement rates and timing for submitting certain claims.
Read the AHA Special Bulletin for more details.
Related News Articles
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…